Target intelligence / Profile preview

Microplastic particle (MP)

Target
MP
Molecular classification
Other
01

Overview

Microplastic particles (MPs) are synthetic polymer contaminants that accumulate in the gastrointestinal tract, leading to intestinal barrier dysfunction, oxidative stress, and inflammatory responses (Luo et al., 2021, Journal of Hazardous Materials). In the context of probiotic-mediated removal, these particles act as the target for sequestration by specific bacterial strains like Lactobacillus plantarum CCFM8610. The mechanism involves the co-aggregation of MPs with bacterial cell-surface components, such as proteins and extracellular polymeric substances (EPS), which physically trap the particles (Hamad et al., 2023, Microorganisms). This interaction prevents the microplastics from adhering to or penetrating the intestinal mucosa, thereby facilitating their clearance through fecal excretion. By reducing the bioavailability and residence time of MPs in the gut, probiotics serve as a biotherapeutic approach to mitigate the systemic toxicity and dysbiosis associated with chronic microplastic ingestion (Deng et al., 2017, Scientific Reports).

Other names
MicroplasticsNanoplasticsGastrointestinal microplasticsSynthetic polymer particlesMPs
02

Mechanism of action

Probiotic bacterial cell-surface co-aggregation and sequestration leading to enhanced fecal excretion and reduced intestinal absorption.

03

Biological functions

Other
04

Disease associations

InflammationOxidative stressGastrointestinal disorderDysbiosisIntestinal permeability
05

Safety considerations

Potential for bacteria-MP complexes to alter microbial community structureUnknown long-term effects of sequestered particle transitStrain-specific binding affinityPotential for particle translocation if barrier is severely compromised
06

Interacting drugs

Lactobacillus plantarum

3 more in the full profile.

07

Biomarkers

Fecal microplastic concentrationMalondialdehyde (MDA) levelsGlutathione peroxidase (GSH-Px) activityTight junction protein expression (e.g., Occludin, ZO-1)Pro-inflammatory cytokines (IL-6, TNF-alpha)

Beyond the preview

Go deeper on Microplastic particle (MP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microplastic particle (MP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call